MedVi vs CoreAgeRx: Pricing, meds, and process compared
MedVi vs CoreAgeRx comes down to two clear tradeoffs: MedVi emphasizes a promotional low first-month price and 24/7 certified medical support for compounded semaglutide, while CoreAgeRx emphasizes same-price-every-month plans and offers tirzepatide as well as semaglutide. Early verdict: choose MedVi if you want a low promotional entry and no clinic visits; choose CoreAgeRx if you want predictable flat monthly pricing and access to tirzepatide.
Start MedVi: See $179 winter promo
Direct comparison overview: MedVi vs CoreAgeRx
This comparison uses only captured facts. MedVi provides clinically dosed compounded semaglutide starting at $179 for a promotional first month, includes fast, free shipping, and advertises 24/7 support from certified medical professionals. CoreAgeRx advertises flat monthly pricing with no membership fee: semaglutide at $79 per month up to 1.0 mg and tirzepatide at $129 per month up to 7.5 mg, with the promise of the same price every month.
Key differences that matter
1. Pricing model and ongoing cost
MedVi: promotional first month starting at $179, with the source noting a standalone month at $299 after the first month and a three-month plan at $649 (about $216/month). The captured evidence explicitly warns that ongoing price is substantially higher than the first-month promo.
CoreAgeRx: advertised “Same Price. Every Month.” with flat monthly pricing and no membership fee. The captured details list semaglutide at $79/month and tirzepatide at $129/month and emphasize no price hike as doses change or over time.
2. Medication options and formulation
MedVi: offers clinically dosed compounded semaglutide only. The evidence notes compounded semaglutide uses the same active ingredient as branded products but also includes the regulatory caution that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
CoreAgeRx: advertises both tirzepatide and semaglutide options. The capture states tirzepatide up to 7.5 mg and semaglutide up to 1.0 mg at separate flat monthly prices and includes a regulatory reminder that medication-specific approval status must be confirmed.
3. Process and support
MedVi: highlights a simple online intake with no clinic visits needed and 24/7 support from certified medical professionals. Their program description notes an online clinician review and that OpenLoop Health clinicians retain prescription decisions.
CoreAgeRx: advertises a 3-minute online visit and clinician review, and stresses that treatment is available only when a licensed clinician determines it is medically appropriate. The captured evidence does not detail 24/7 support for CoreAgeRx.
4. Pricing transparency and membership
MedVi: landing-page text asserts “No membership or hidden fees!” but captured copy also references membership options in other parts of the source, and FAQ captures mention that MedVi operates on a direct-pay model and does not bill insurance.
CoreAgeRx: repeatedly emphasizes no membership fee, no hidden fees, and “same price every month,” framing predictability as its primary selling point.
| Criteria | MedVi | CoreAgeRx |
|---|---|---|
| Starting price | Promotional first month $179 (includes fast, free shipping) | Semaglutide $79/mo; Tirzepatide $129/mo |
| Ongoing pricing | Standalone month $299; 3-month plan $649 (~$216/mo) | Same price every month; no membership fee |
| Medications offered | Compounded semaglutide only | Semaglutide and tirzepatide options |
| Formulation note | Compounded semaglutide; compounded meds not FDA-approved | Includes reminder to confirm medication-specific approval status |
| Process | Simple online intake, no clinic visits, clinician review | 3-minute online visit; clinician review required |
| Support | 24/7 support from certified medical professionals | Support details not captured |
How each provider frames risks and limits
Both sources capture clinician discretion: MedVi notes OpenLoop Health clinicians meet with patients after checkout and retain prescribing decisions; CoreAgeRx states treatment is available only when a licensed clinician determines it is medically appropriate. MedVi also explicitly states that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. CoreAgeRx captured text similarly cautions to confirm medication-specific approval status.
Which provider fits your needs?
MedVi is best for people who prioritize a low promotional entry price, fast free shipping, a fully online intake without clinic visits, and explicit 24/7 certified medical support. CoreAgeRx is best for people who prioritize predictable, same-price-every-month billing, and who want access to tirzepatide as well as semaglutide at clearly stated flat monthly rates.
Compare MedVi plans and details
Conclusion: MedVi vs CoreAgeRx
MedVi vs CoreAgeRx splits on cost predictability and medication variety. Use MedVi if you want a promotional $179 first month, no clinic visits, and 24/7 certified medical support with compounded semaglutide. Use CoreAgeRx if you want flat monthly pricing with no membership fees and the option of tirzepatide or semaglutide at stated monthly rates. Remember the captured sources note clinician review is required for prescriptions and compounded medications are not FDA-approved; confirm medication-specific approval status when relevant.
Choose MedVi if…
- You value a low promotional first-month price ($179) and fast, free shipping.
- You want a no-clinic-visit online intake and 24/7 certified medical support.
- You accept compounded semaglutide and the accompanying regulatory notes in the source.
Choose CoreAgeRx if…
- You prefer same-price-every-month billing and no membership fees.
- You want access to tirzepatide up to 7.5 mg as well as semaglutide up to 1.0 mg at flat monthly rates.